Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734867 | SCV000863045 | uncertain significance | not provided | 2018-08-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868997 | SCV002153275 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2022-08-15 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 598470). This variant has not been reported in the literature in individuals affected with SDCCAG8-related conditions. This variant is present in population databases (rs772853104, gnomAD 0.003%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 446 of the SDCCAG8 protein (p.Arg446Gln). |
Fulgent Genetics, |
RCV001868997 | SCV002789908 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2022-05-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535879 | SCV004105360 | uncertain significance | SDCCAG8-related disorder | 2023-09-22 | criteria provided, single submitter | clinical testing | The SDCCAG8 c.1337G>A variant is predicted to result in the amino acid substitution p.Arg446Gln. This variant was reported as a heterozygous variant of uncertain significance in an individual with Bardet-Biedl syndrome (Nasser et al. 2022. PubMed ID: 35886001). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-243504456-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |